We’re excited to join industry leaders at Advanced Therapies Week 2026 in San Diego from February 9-12.
Visit us at Partnering Village C, Table 2, to discover how Corning helps you accelerate from research to commercial success with confidence and consistency.
We have decades of a deep understanding of cell biology and material science expertise to help you accelerate the path from experimenting with cells in your lab to delivering breakthrough therapies and drugs designed to improve and save lives — faster than you ever thought possible.
Corning supports research tools used in the production of advanced therapies, with a portfolio of products across key areas including:
- Cell therapies utilizing mesenchymal stromal/stem cells (MSCs) and induced pluripotent stem cells (iPSCs)
- Gene therapies at the forefront of precision medicine
From vessels and surfaces to media and serum, to final drug storage, we provide more than 30,000 products that deliver consistent, reliable performance as you scale up or out from the research lab to the production suite, including:
- Stacked vessel designs that deliver precise batch-batch consistency as you scale out or up from small to large, including Corning® HYPERFlask®, HYPERStack®, and CellSTACK® vessels.
- Pre-coated vessels that reduce steps, save time, and deliver reliability scaling.
- Closed-system vessels and customizable configurations that mitigate contamination risks, optimize workflows, and ensure regulatory compliance.
- Corning CellCube® and Ascent® platforms utilize dynamic media conditioning with automated process monitoring and control, offering flexibility to meet your specific production requirements.
- Corning’s MSCulture Max™ media is tailored to maximize efficiency in MSC expansion. It increases final hMSC yields, streamlines culture processes, and reduces in-process risks by eliminating the need for media exchanges and requires no surface coating.
